Growing community of inventors

Milan, Italy

Zulma Magnani

Average Co-Inventor Count = 7.72

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 35

Zulma MagnaniMaria Chiara Bonini (3 patents)Zulma MagnaniMichael C Holmes (2 patents)Zulma MagnaniPhilip D Gregory (2 patents)Zulma MagnaniDavid Paschon (2 patents)Zulma MagnaniLei Zhang (2 patents)Zulma MagnaniLuigi Naldini (2 patents)Zulma MagnaniPietro Genovese (2 patents)Zulma MagnaniSara Mastaglio (2 patents)Zulma MagnaniAttilio Bondanza (1 patent)Zulma MagnaniEliana Ruggiero (1 patent)Zulma MagnaniLuca Aldo Edoardo Vago (1 patent)Zulma MagnaniFabio Ciceri (1 patent)Zulma MagnaniZulma Magnani (3 patents)Maria Chiara BoniniMaria Chiara Bonini (10 patents)Michael C HolmesMichael C Holmes (64 patents)Philip D GregoryPhilip D Gregory (62 patents)David PaschonDavid Paschon (49 patents)Lei ZhangLei Zhang (43 patents)Luigi NaldiniLuigi Naldini (24 patents)Pietro GenovesePietro Genovese (8 patents)Sara MastaglioSara Mastaglio (2 patents)Attilio BondanzaAttilio Bondanza (5 patents)Eliana RuggieroEliana Ruggiero (1 patent)Luca Aldo Edoardo VagoLuca Aldo Edoardo Vago (1 patent)Fabio CiceriFabio Ciceri (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Ospedale San Raffaele S.r.l. (3 from 50 patents)

2. Sangamo Therapeutics, Inc. (2 from 145 patents)

3. Fondazione Centro San Raffaele (1 from 5 patents)


3 patents:

1. 11597755 - TCR and peptides

2. 10918668 - Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases

3. 9937207 - Targeted disruption of T cell receptor genes using talens

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…